Feature | SCAI | May 01, 2017

Late-Breaking Clinical Trial Presentations at SCAI 2017

a list of SCAI late breaking trial presentations

May 30, 2017 — The Society for Cardiovascular Angiography and Interventions (SCAI) 2017 Scientific Sessions took place May 10-13, 2017 in New Orleans. The annual meeting included several late-breaking presentations on the latest advances in interventional cardiology. Article links are included for the key presentations.

 

Late-breaking Study Presentations

Adventitial Dexamethasone Reduces Inflammatory Biomarker Levels After Peripheral Artery Balloon Angioplasty or Atherectomy: Results from the DANCE Trial. Presented by Ehrin J. Armstrong, M.D., MSc, MAS, FSCAI.

CD34+ Stem Cell Therapy Improves Exercise Time and Mortality in Refractory Angina: A Patient Level Meta-Analysis. Presented by Thomas J. Povsic, M.D., Ph.D.

Effect of Bivalirudin Versus Unfractionated Heparin in Patients with Baseline or New-Onset Atrial Fibrillation in Transcatheter Aortic Valve Replacement: From the BRAVO-3 Randomized Trial. Presented by Anita W. Asgar

Clopidogrel Response Evaluation and Anti-Platelet Intervention in High Thrombotic Risk PCI Patients (CREATIVE trial). Presented by Yida Tang, M.D., Ph.D., FSCAI.

Impact of Valve Design and Bivalirudin vs. Unfractionated Heparin for Anticoagulation in Transcatheter Aortic Valve Replacement: Results from the BRAVO-3 trial. Presented by Axel Linke, M.D.

Interaction Effects of Race/Ethnicity and Sex on Outcomes after PCI: A Subanalysis of the PLATINUM Diversity study. Presented by Wayne B. Batchelor, M.D., MHS, FSCAI.

Outcomes of Early vs. Late Revascularization in Low and High Risk Patients Hospitalized with Non ST-Elevation Myocardial Infarction: The Atherosclerosis Risk in Communities (ARIC) Surveillance Study. Presented by Sameer Arora, M.D., at 11:30 a.m. 

Efficacy and Safety Outcomes of Radial vs. Femoral-Access Robotic Percutaneous Coronary Intervention: Final Results of the Multicenter PRECISION Registry. Presented by Ehtisham Mahmud, M.D., FSCAI.

• Day of the Week PCI-Related Hospitalization Occurs Determines Likelihood of Survival. Presented by Byomesh Tripathi, M.D.

 

SCAI Video Coverage

Watch VIDEO coverage of key SCAI 2017 news, courses and trials at www.youtube.com/playlist?list=PLYpLxw1Ganwa5kJFa3TrFAY5l1-Jeu9Ax

 

Late-breaking Trials From TCT and ACC: 

ACC 2017 Late-Breaking Trials

TCT 2016 Late-breaking Trials and First Reports

 

For more information: www.scai.org/SCAI2017/default.aspx

Related Content

DISRUPT BTK Study Shows Positive Results With Lithoplasty in Calcified Lesions Below the Knee
News | Peripheral Artery Disease (PAD)| September 20, 2017
Shockwave Medical reported positive results from the DISRUPT BTK Study, which were presented at the annual...
Corindus Announces First Patient Enrolled in PRECISION GRX Registry
News | Robotic Systems| September 18, 2017
September 18, 2017 — Corindus Vascular Robotics Inc.
Two-Year ILLUMENATE Trial Data Demonstrate Efficacy of Stellarex Drug-Coated Balloon
News | Drug-Eluting Balloons| September 18, 2017
Philips announced the two-year results from the ILLUMENATE European randomized clinical trial (EU RCT) demonstrating...
Sentinel Cerebral Protection System Significantly Reduces Stroke and Mortality in TAVR
News | Embolic Protection Devices| September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the...
Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Marijuana Associated With Three-Fold Risk of Death From Hypertension
News | Hypertension| September 14, 2017
Marijuana use is associated with a three-fold risk of death from hypertension, according to research published recently...
Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Feature | Cath Lab| September 14, 2017
September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials
Mississippi Surgical and Vascular Center Uses Toshiba Ultimax-i FPD to Save Patients' Limbs
News | Angiography| September 14, 2017
The southern U.S. sees some of the highest numbers of chronic medical conditions, such as peripheral artery disease...
Sponsored Content | Videos | Structural Heart Occluders| September 13, 2017
Ziyad Hijazi, M.D., MPH, MSCAI, FACC, director of the cardiac program and chair of the Department of Pediatrics at Si
Philips Showcases Integrated Vascular Solutions at VIVA 2017
News | Peripheral Artery Disease (PAD)| September 13, 2017
Philips announced its presence at the Vascular Interventional Advances (VIVA 17) Annual Conference in Las Vegas from...
Overlay Init